$QLGN
Qualigen Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224045921 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.145M
YoY Change -14.33%
% of Gross Profit
Research & Development $123.4K
YoY Change -91.44%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.269M
YoY Change -54.34%
Operating Profit -$1.269M
YoY Change -54.34%
Interest Expense $28.00K
YoY Change -107.62%
% of Operating Profit
Other Income/Expense, Net -$527.7K
YoY Change 15.55%
Pretax Income -$1.796M
YoY Change -44.47%
Income Tax -$2.198K
% Of Pretax Income
Net Earnings -$1.794M
YoY Change -51.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$4.70
COMMON SHARES
Basic Shares Outstanding 736.4K shares 12.16M shares
Diluted Shares Outstanding 387.9K shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $388.2K
YoY Change -81.28%
Cash & Equivalents $388.2K
Short-Term Investments
Other Short-Term Assets $626.8K
YoY Change -54.44%
Inventory
Prepaid Expenses
Receivables $1.298M
Other Receivables $0.00
Total Short-Term Assets $2.313M
YoY Change -32.95%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $2.313M
Total Long-Term Assets $0.00
Total Assets $2.313M
YoY Change -46.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.638M
YoY Change 4.24%
Accrued Expenses $570.1K
YoY Change -50.17%
Deferred Revenue
YoY Change
Short-Term Debt $1.434M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.454M
YoY Change -25.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.454M
Total Long-Term Liabilities $0.00
Total Liabilities $4.454M
YoY Change -25.23%
SHAREHOLDERS EQUITY
Retained Earnings -$122.2M
YoY Change 6.82%
Common Stock $65.31K
YoY Change 52.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.141M
YoY Change
Total Liabilities & Shareholders Equity $2.313M
YoY Change -46.41%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.794M
YoY Change -51.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.800M
YoY Change -294.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.250M
YoY Change -131.4%
Cash From Investing Activities -$1.250M
YoY Change -129.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.319M
YoY Change -854.39%
NET CHANGE
Cash From Operating Activities -1.800M
Cash From Investing Activities -1.250M
Cash From Financing Activities 3.319M
Net Change In Cash 269.5K
YoY Change -94.29%
FREE CASH FLOW
Cash From Operating Activities -$1.800M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3474527
dei Entity Address Address Line1
EntityAddressAddressLine1
5857 Owens Avenue, Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
dei City Area Code
CityAreaCode
(760)
dei Local Phone Number
LocalPhoneNumber
452-8111
dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
dei Trading Symbol
TradingSymbol
QLGN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
736431 shares
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
626760 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
548284 shares
CY2024Q3 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2024Q3 us-gaap Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
CY2023Q3 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
usd
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
QLGN Accrued Interest On Shortterm Note Receivable
AccruedInterestOnShorttermNoteReceivable
usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
QLGN Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
QLGN Fair Value Of Warrant Modification For Professional Services
FairValueOfWarrantModificationForProfessionalServices
usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
QLGN Issuance Of Shortterm Note Receivable
IssuanceOfShorttermNoteReceivable
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
QLGN Monthly Redemptions Of Convertible Debt Into Common Stock
MonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
QLGN Deemed Dividend Arising From Warrant Downround Provision
DeemedDividendArisingFromWarrantDownroundProvision
usd
QLGN Exchange Of Derivative Liability For Warrant And Convertible Debt
ExchangeOfDerivativeLiabilityForWarrantAndConvertibleDebt
usd
QLGN Net Transfers To Equipment Held For Lease From Inventory
NetTransfersToEquipmentHeldForLeaseFromInventory
usd
CY2023Q4 QLGN Prepaid Consulting
PrepaidConsulting
usd
CY2024Q3 QLGN Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
usd
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
usd
CY2024Q3 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
usd
CY2024Q3 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
usd
QLGN Fair Value Of Warrant Liabilities On Date Of Exercise
FairValueOfWarrantLiabilitiesOnDateOfExercise
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity Registrant Name
EntityRegistrantName
Qualigen Therapeutics, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-37428
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
388152 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
401803 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
764964 usd
CY2024Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
1298082 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
2312994 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1166767 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
866481 usd
CY2024Q3 us-gaap Assets
Assets
2312994 usd
CY2023Q4 us-gaap Assets
Assets
2033248 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1638447 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2222983 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
570148 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
560006 usd
CY2024Q3 QLGN Warrant Liabilities Current
WarrantLiabilitiesCurrent
274042 usd
CY2023Q4 QLGN Warrant Liabilities Current
WarrantLiabilitiesCurrent
54600 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4453845 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4136805 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
548284 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107243 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107243 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
65314 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43262 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119999588 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
114655565 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122205753 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-116802384 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2140851 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2103557 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2312994 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2033248 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1145152 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1336765 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3186575 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5132834 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
123429 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1441598 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1242101 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3898061 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1268581 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2778363 usd
us-gaap Operating Expenses
OperatingExpenses
4428676 usd
us-gaap Operating Expenses
OperatingExpenses
9030895 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1268581 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2778363 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4428676 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9030895 usd
CY2024Q3 QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
1231 usd
CY2023Q3 QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
-101112 usd
QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
361137 usd
QLGN Gain On Change In Fair Value Of Warrant Liabilities
GainOnChangeInFairValueOfWarrantLiabilities
1377855 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-495693 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-321080 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408359 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
367257 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
808477 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1288908 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
48082 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
48082 usd
QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
358279 usd
CY2024Q3 QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
-27790 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
56010 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
-1077287 usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
208852 usd
CY2024Q3 QLGN Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
348305 usd
QLGN Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
348305 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-21747 usd
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-21747 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6547 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33454 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9262 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33534 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-527677 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-456662 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-873892 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-976553 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1796258 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3235025 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5302568 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10007448 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2198 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1794060 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3235025 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5303368 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10007448 usd
CY2023Q3 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
159507 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-683008 usd
CY2023Q3 us-gaap Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
619545 usd
us-gaap Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
100000 usd
us-gaap Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax
DiscontinuedOperationProvisionForLossGainOnDisposalNetOfTax
619545 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-460038 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1302553 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1794060 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3695063 usd
us-gaap Profit Loss
ProfitLoss
-5403368 usd
us-gaap Profit Loss
ProfitLoss
-11310001 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-38526 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-343038 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1794060 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-3656537 usd
us-gaap Net Income Loss
NetIncomeLoss
-5403368 usd
us-gaap Net Income Loss
NetIncomeLoss
-10966963 usd
CY2024Q3 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
27587 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
87604 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1821647 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3656537 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5490972 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10966963 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-4.70
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-4.70
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-32.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-32.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-24.48
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-24.48
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-99.64
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-99.64
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-4.17
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-4.17
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.45
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.45
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-9.55
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-9.55
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.70
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.70
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-36.18
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-36.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-24.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-24.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-109.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-109.19
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
387878 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
387878 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101049 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101049 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220221 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
220221 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100434 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100434 shares
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1794060 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3695063 usd
us-gaap Profit Loss
ProfitLoss
-5403368 usd
us-gaap Profit Loss
ProfitLoss
-11310001 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-50721 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1794060 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-3695063 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5403368 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11360722 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-38526 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-343038 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1794060 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3656537 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5403368 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11017684 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2103557 usd
CY2024Q1 QLGN Stock Issued During Period Value Monthly Redemptions Of Convertible Debt Into Common Stock
StockIssuedDuringPeriodValueMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
546232 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
9737 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
58651 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2032751 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3521688 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
280201 usd
CY2024Q2 QLGN Stock Issued During Period Value Monthly Redemptions Of Convertible Debt Into Common Stock
StockIssuedDuringPeriodValueMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
357096 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
150000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
33086 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-1576558 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4277863 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3053348 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
454883 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2299 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
265981 usd
CY2024Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
142351 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
14998 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
27208 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-1794060 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2140851 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8766590 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1112582 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
252226 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
176220 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-4107249 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6200369 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6200369 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
672111 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-56747 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3507689 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3308044 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
113801 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-3695063 usd
CY2023Q3 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
1367334 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1640552 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1640552 usd
us-gaap Profit Loss
ProfitLoss
-5403368 usd
us-gaap Profit Loss
ProfitLoss
-11310001 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-100000 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1302553 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-5303368 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10007448 usd
us-gaap Share Based Compensation
ShareBasedCompensation
118945 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1028841 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-361137 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1377855 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-321080 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001460702
CY2023Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2024Q3 QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2023Q3 QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
QLGN Loss On Issuance Of Convertible Debt
LossOnIssuanceOfConvertibleDebt
usd
CY2023Q3 QLGN Gain Loss On Voluntary Conversion Of Convertible Debt Into Common Stock
GainLossOnVoluntaryConversionOfConvertibleDebtIntoCommonStock
usd
CY2024Q3 QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
CY2023Q3 QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
usd
CY2023Q3 QLGN Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
usd
QLGN Gain On Settlements Of Accounts Payable
GainOnSettlementsOfAccountsPayable
usd
QLGN Accrued Interest On Shortterm Note Receivable
AccruedInterestOnShorttermNoteReceivable
48082 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt
GainLossOnVoluntaryConversionOfConvertibleDebt
-56010 usd
QLGN Gain Loss On Voluntary Conversion Of Convertible Debt
GainLossOnVoluntaryConversionOfConvertibleDebt
1077287 usd
QLGN Loss On Monthly Redemptions Of Convertible Debt Into Common Stock
LossOnMonthlyRedemptionsOfConvertibleDebtIntoCommonStock
208852 usd
QLGN Accretion Of Discount On Convertible Debt
AccretionOfDiscountOnConvertibleDebt
-514028 usd
QLGN Accretion Of Discount On Convertible Debt
AccretionOfDiscountOnConvertibleDebt
-1247198 usd
QLGN Gain Loss On Issuance Of Convertible Debt
GainLossOnIssuanceOfConvertibleDebt
-358279 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-21747 usd
QLGN Fair Value Of Warrant Modification For Professional Services
FairValueOfWarrantModificationForProfessionalServices
12036 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-554685 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
640105 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-584537 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
952269 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
207249 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
443330 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4057980 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-7254736 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
2622059 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4057980 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4632677 usd
QLGN Issuance Of Shortterm Note Receivable
IssuanceOfShorttermNoteReceivable
1250000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
350000 usd
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
3980541 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-900000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3980541 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
1475000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-440000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3053348 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2000000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
415981 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2000000 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4944329 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-440000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4944329 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-440000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-13651 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1092136 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
401803 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3165985 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388152 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2073849 usd
us-gaap Interest Paid Net
InterestPaidNet
61020 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7864 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4900 usd
QLGN Monthly Redemptions Of Convertible Debt Into Common Stock
MonthlyRedemptionsOfConvertibleDebtIntoCommonStock
903329 usd
QLGN Voluntary Conversion Of Convertible Debt Into Common Stock
VoluntaryConversionOfConvertibleDebtIntoCommonStock
735083 usd
QLGN Voluntary Conversion Of Convertible Debt Into Common Stock
VoluntaryConversionOfConvertibleDebtIntoCommonStock
1112582 usd
QLGN Deemed Dividend Arising From Warrant Downround Provision
DeemedDividendArisingFromWarrantDownroundProvision
-87604 usd
QLGN Exchange Of Derivative Liability For Warrant And Convertible Debt
ExchangeOfDerivativeLiabilityForWarrantAndConvertibleDebt
-675625 usd
QLGN Net Transfers To Equipment Held For Lease From Inventory
NetTransfersToEquipmentHeldForLeaseFromInventory
-83271 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_z0vv5TC2iKAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zCKKZgooZpql">Accounting Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management uses estimates and assumptions in preparing its condensed consolidated financial statements in accordance with U.S. GAAP. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. The most significant estimates relate to the estimated fair value of warrant liabilities, convertible debentures, derivative liabilities, and stock-based compensation. Actual results could materially vary from the estimates that were used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Cash
Cash
388000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122200000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4000000.0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11000000 usd
CY2024Q2 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1500000 usd
CY2024Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000.0 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
313703 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
566011 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
63057 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
25053 usd
CY2024Q3 QLGN Prepaid Consulting
PrepaidConsulting
250000 usd
CY2023Q4 QLGN Prepaid Research And Development Expenses
PrepaidResearchAndDevelopmentExpenses
173900 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
626760 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
764964 usd
CY2024Q3 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
1298082 usd
CY2024Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
1298082 usd
CY2023Q3 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
159507 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-683008 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
619545 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
619545 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-100000 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-460038 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1302553 usd
CY2024Q2 us-gaap Escrow Deposits Related To Property Sales
EscrowDepositsRelatedToPropertySales
350000 usd
us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
100000 usd
CY2024Q3 QLGN Accrued Compensation
AccruedCompensation
97597 usd
CY2023Q4 QLGN Accrued Compensation
AccruedCompensation
129499 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
68318 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10004 usd
CY2024Q3 QLGN Accrued License Fees
AccruedLicenseFees
4907 usd
CY2023Q4 QLGN Accrued License Fees
AccruedLicenseFees
32975 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
3173 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1215 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
163270 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
121775 usd
CY2024Q3 QLGN Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
61515 usd
CY2023Q4 QLGN Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
104402 usd
CY2024Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
164095 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
151286 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7273 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8850 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
570148 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
560006 usd
CY2024Q2 QLGN Fair Value Of Warrant Liabilities On Date Of Granted
FairValueOfWarrantLiabilitiesOnDateOfGranted
565582 usd
CY2024Q3 QLGN Fair Value Of Warrant Liabilities Current
FairValueOfWarrantLiabilitiesCurrent
257492 usd
CY2024Q3 QLGN Gain On Change In Fair Value Of Warrants
GainOnChangeInFairValueOfWarrants
2784 usd
QLGN Gain On Change In Fair Value Of Warrants
GainOnChangeInFairValueOfWarrants
308090 usd
CY2023Q4 QLGN Fair Value Adjustment Of Warrant
FairValueAdjustmentOfWarrant
54600 usd
QLGN Fair Value Of Warrant Liabilities On Date Of Granted
FairValueOfWarrantLiabilitiesOnDateOfGranted
565582 usd
QLGN Fair Value Of Warrant Liabilities On Date Of Reclassified From Equity
FairValueOfWarrantLiabilitiesOnDateOfReclassifiedFromEquity
14997 usd
QLGN Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-361137 usd
CY2024Q3 QLGN Fair Value Adjustment Of Warrant
FairValueAdjustmentOfWarrant
274042 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
124000 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
28000 usd
us-gaap Interest Expense
InterestExpense
162000 usd
CY2024Q3 QLGN Accretion Discount Inculded In Interest Expense
AccretionDiscountInculdedInInterestExpense
28000 usd
QLGN Accretion Discount Inculded In Interest Expense
AccretionDiscountInculdedInInterestExpense
120000 usd
CY2024Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
368000 usd
us-gaap Interest Expense
InterestExpense
1300000 usd
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
350000 usd
us-gaap Accretion Expense
AccretionExpense
1200000 usd
CY2023Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
2200000 usd
CY2023Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
0 usd
CY2024Q2 QLGN Fair Value Of Warrant Liabilities On Date Of Granted
FairValueOfWarrantLiabilitiesOnDateOfGranted
565582 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
342766 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
89523 shares
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1250000 usd
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
590597 shares
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
590597 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
19000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y6M29D
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27208 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113801 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
118944 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1022039 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
0 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
13.00
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.50
CY2024Q3 QLGN Deemed Dividend Arising From Warrant Modification
DeemedDividendArisingFromWarrantModification
27587 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.50

Files In Submission

Name View Source Status
0001493152-24-045921-index-headers.html Edgar Link pending
0001493152-24-045921-index.html Edgar Link pending
0001493152-24-045921.txt Edgar Link pending
0001493152-24-045921-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qlgn-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
qlgn-20240930_cal.xml Edgar Link unprocessable
qlgn-20240930_def.xml Edgar Link unprocessable
qlgn-20240930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
qlgn-20240930_pre.xml Edgar Link unprocessable